Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.373, Iss.4, 2006-07, pp. : 273-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists

By Appendino Giovanni Muñoz Eduardo Fiebich Bernd L

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1825-1837

Informa Healthcare

Access to resources Recommend Favorite

Benzamide-type vanilloid (TRPV1) antagonists

By Appendino Giovanni

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 549-553

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates

Current Medicinal Chemistry, Vol. 14, Iss. 21, 2007-09 ,pp. : 2257-2277

Bentham Science Publishers

Access to resources Recommend Favorite

TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications

By Avelino António Cruz Francisco

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 4, 2006-07 ,pp. : 287-299

Springer Publishing Company

Access to resources Recommend Favorite

Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature

By Voight Eric A Kort Michael E

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1107-1122

Informa Healthcare

Access to resources Recommend Favorite